Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Hawaii Med J ; 66(7): 181-4, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17879855

RESUMEN

Results from mailed surveys (n = 424) showed that 28% of adult Filipinos were a designated organ donor on their driver's license. In logistic regression analyses respondents who were born in the United States were 3.5 times more likely to be a designated donor compared with foreign-born Filipinos. Future programs should emphasize the need for Filipinos, especially immigrants, to become organ donors.


Asunto(s)
Asiático/psicología , Actitud Frente a la Salud/etnología , Emigrantes e Inmigrantes/psicología , Donantes de Tejidos/psicología , Obtención de Tejidos y Órganos/estadística & datos numéricos , Adulto , Conducción de Automóvil , Hawaii , Encuestas de Atención de la Salud , Humanos , Evaluación de Necesidades , Filipinas/etnología , Proyectos Piloto , Encuestas y Cuestionarios , Donantes de Tejidos/provisión & distribución
2.
J Consult Clin Psychol ; 74(2): 286-94, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16649873

RESUMEN

The authors present results of a randomized clinical trial of the efficacy of extended treatment with bupropion SR in producing longer term cigarette smoking cessation. Adult smokers (N = 362) received open-label treatment (11 weeks) that combined relapse prevention training, bupropion SR, and nicotine patch followed by extended treatment (14 weeks) with bupropion SR or matching placebo. Abstinence percentages were relatively high (week 11: 52%; week 25: bupropion, 42%; placebo, 38%; week 52: bupropion, 33%; placebo, 34%), but bupropion SR did not surpass placebo. Gender and baseline craving level were identified as significant, independent moderators of treatment response. Men were more likely to abstain than women (week 11: 59% vs. 43%, p = .001; week 25: 48% vs. 31%, p = .001; week 52: 39% vs. 27%, p = .01). Because most smokers suffer relapse with any current cessation treatment, the comparatively high abstinence percentages achieved in this trial are of interest.


Asunto(s)
Bupropión/uso terapéutico , Cese del Hábito de Fumar/métodos , Fumar/tratamiento farmacológico , Adolescente , Adulto , Anciano , Bupropión/administración & dosificación , Preparaciones de Acción Retardada/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA